Screening for down syndrome during first trimester: A prospective study using free β-human chorionic gonadotropin and pregnancy-associated plasma protein A

This publication has 22 references indexed in Scilit:

• First trimester serum screening for down's syndrome
  Prenatal Diagnosis, 1995
• Screening for Down syndrome during the first and second trimesters: Impact of risk estimation parameters
  Clinical Biochemistry, 1995
• Serum PAPP‐A and free β‐hCG are first‐trimester screening markers for down syndrome
  Prenatal Diagnosis, 1994
• First Trimester Biochemical Screening for Trisomy 21: The Role of Free Beta hCG, Alpha Fetoprotein and Pregnancy Associated Plasma Protein A
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1994
• Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme
  Prenatal Diagnosis, 1994
• Serum PAPP‐A measurements in first‐trimester screening for Down syndrome
  Prenatal Diagnosis, 1993
• Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
  BMJ, 1993
• Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancy
  Prenatal Diagnosis, 1993
• First‐trimester free beta (hCG) screening for Down syndrome
  Prenatal Diagnosis, 1993
• Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
  BMJ, 1992